Skip to content
★ Sign in to follow
Medico Intercontinental logo

Medico Intercontinental Stock: price and insider trades · India

IN·Mcap ₹240M

No insider purchase over the last 90 days. The latest, by Samir Shah & PACs, was filed 22 Jul 2026.

Medico Intercontinental: what insiders have been doing

Medico Intercontinental is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 2 insiders published 2 filings.

Only purchases show up on the open market, 2 purchases in all worth €38k, filed by 2 insiders. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Samir Dilipkumar Shah filed the largest purchase, €38k, on 25 June 2026. Among those who bought: 1 major shareholder and 1 senior executive.

The last insider purchase was made public on 22 July 2026, 109 days ago.

Across the 1,985 companies tracked on its exchange, the median is 4 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.

Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€37,789
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Samir Dilipkumar Shah1 buy
Samir Shah & PACs1 buy

Since the insiders bought

  • Filed 25 Jun 2026 · 136 days ago · €38k
    -19.2%
    Entry ₹29.22 · Close at T+90 ₹23.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,651 of 26,897 companies
30.3
score / 100
Value
43
Quality
17
FCF yld49%
Earn yld-13%
EV/EBITDA22.8x
ROE-27%
Gross mgn25%
Net mgn-3.8%
Debt/EBITDA16.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹24.00
Analyst consensus
·
Income statement
Revenue₹840.8M
Gross profit₹214.3M25% margin
EBITDA₹40.6M5% margin
Net income-₹32M-4.7% margin
Valuation
P/Book0.5x
Beta-1.08
Balance sheet & cash
Market cap₹240M
Total debt₹672.3M
Free Cash Flow₹124.3M
Debt / Equity208%
Profitability & ownership
ROE-27.1%
ROA-0.8%
% insiders61.3%
% institutions0.0%
Last declaration on 22 July 2026
Declarations2 total
  • ▲
    PromoterExecutives
    0SEBI
    136,886 shares-MarketSEBI:8bded2414d04cd5ace209d5ccade25a819352807
    Canonical exit: 20 Oct 2026 (T+90)
  • ▲
    Promoter & DirectorExecutives
    4M INR19SEBI
    136,886 shares@ ₹29.60100.0% of flowEquity SharesMarket PurchaseSEBI:c10f1a86391a733ba85e182f691276a9b7a9cdd3
    Canonical exit: 23 Sept 2026 (T+90)

2 of 2 declarations

About Medico Intercontinental

Medico Intercontinental is a company operating in the XBOM market, specializing in the medical sector.